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OBJECTIVE: In most cases of pediatric liver transplantation, the clinical scenario of large-for-size transplants can
lead to hepatic dysfunction and a decreased blood supply to the liver graft. The objective of the present
experimental investigation was to evaluate the effects of ischemic preconditioning on this clinical entity.
METHODS: Eighteen pigs were divided into three groups and underwent liver transplantation: a control group,
in which the weights of the donors were similar to those of the recipients, a large-for-size group, and a large-
for-size + ischemic preconditioning group. Blood samples were collected from the recipients to evaluate the pH
and the sodium, potassium, aspartate aminotransferase and alanine aminotransferase levels. In addition,
hepatic tissue was sampled from the recipients for histological evaluation, immunohistochemical analyses to
detect hepatocyte apoptosis and proliferation and molecular analyses to evaluate the gene expression of Bax
(pro-apoptotic), Bcl-XL (anti-apoptotic), c-Fos and c-Jun (immediate-early genes), ischemia-reperfusion-related
inflammatory cytokines (IL-1, TNF-alpha and IL-6, which is also a stimulator of hepatocyte regeneration),
intracellular adhesion molecule, endothelial nitric oxide synthase (a mediator of the protective effect of
ischemic preconditioning) and TGF-beta (a pro-fibrogenic cytokine).
RESULTS: All animals developed acidosis. At 1 hour and 3 hours after reperfusion, the animals in the large-for-
size and large-for-size + ischemic preconditioning groups had decreased serum levels of Na and increased serum
levels of K and aspartate aminotransferase compared with the control group. The molecular analysis revealed
higher expression of the Bax, TNF-alpha, I-CAM and TGF-beta genes in the large-for-size group compared with
the control and large-for-size + ischemic preconditioning groups. Ischemic preconditioning was responsible for
an increase in c-Fos, IL-1, IL-6 and e-NOS gene expression.
CONCLUSION: Ischemia-reperfusion injury in this model of large-for-size liver transplantation could be partially
attenuated by ischemic preconditioning.
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& INTRODUCTION
With the improvement in the management of pediatric
patients with terminal liver diseases and the technical
refinement and advances in intensive care and immuno-
suppression, liver transplantation has been performed in
increasingly young children (1); a large series of liver
transplantations in recipients that were less than 10 or even
5 kg have been reported with satisfactory results (1,2).
However, a problem encountered by surgeons in such cases
is the graft-to-body weight ratio (GBWR). Classically, the
ideal ratio varies from 1 to 3%. However, in small children,
the ratio is higher than 5% (3). This situation is known as
large-for-size (LFS) and is characterized by the discrepancy
between the small size of the abdominal cavity and the large
size of the graft, which can lead to hepatic dysfunction and a
diminished blood supply to the liver graft (3). Higher
incidences of graft dysfunction, vascular complications and
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acute rejection have been reported in the literature in cases
involving LFS grafts (3). The mechanisms of injury involved
in this scenario are not yet well established.
Among the main mechanisms of graft injury in trans-
plantation is ischemia-reperfusion injury (IRI) (4), which has
been related to complications such as poor graft function.
Immediate-early genes (IEGs) encode transcription factors
that regulate the expression of cellular response genes after
injury and are associated with tissue repair and cell
apoptosis (5,6). Many studies have shown that c-Fos and c-
Jun are the IEGs that are activated during the early phase
after IR and that they play an important role in the
regulation of the tissue response to injury stimulation
(7,8). Tissue inflammation triggered by IRI occurs immedi-
ately after reperfusion and is related to the production of
cytokines (TNF-alpha, IL-1, IL-6) and increased expression
of adhesion molecules (such as ICAM) (9). The inflamma-
tory cascade that culminates in apoptotic cell death and the
cellular mechanisms of regeneration are the elements
involved in IRI (10,11,12,13,14). The apoptosis phenomenon
results from alterations in the balance between the expres-
sion of pro-apoptotic (Bax and Bak) and anti-apoptotic (Bcl-2
and Bcl-XL) genes. The activation of liver regeneration,
which is essential for graft survival, is mainly mediated by
IL-6 (15,16,17). After liver transplantation, IRI is responsible
for the induction of pro-fibrogenic cytokines, represented
mainly by TGF-beta (18).
Some techniques that attenuate IRI, such as ischemic
preconditioning (IPC), have been reported and the nitric
oxide (NO) produced by endothelial nitric oxide synthase
(eNOS) is an important mediator of the effects of IPC. eNOS
produces a protective action mediated by vasodilation and
platelet aggregation inhibition, thereby improving the
microcirculation in addition to inhibiting neutrophil activa-
tion and neutralizing reactive oxygen species (18,19,20).
Furthermore, it has been demonstrated that IPC stimulates
liver regeneration (21). This effect has been demonstrated in
rats that underwent warm ischemia and hepatectomy and
interleukin-6 (IL-6) has been shown to be a likely mediator
(22). No experimental studies have evaluated early hepatic
injury in the LFS transplant scenario or the effects of IPC in
this situation. Therefore, this was the objective of the present
experimental investigation, which utilized a LFS pig
experimental model of liver transplantation.
& MATERIALS AND METHODS
The institution’s animal welfare regulatory committee
approved all study protocols and all protocols were in
compliance with the Guide for the Care and Use of
Laboratory Animals published by the National Institutes
of Health 86-23, which was revised in 1985. Our study was
performed using 36 Landrace pigs, with body weights
between 20 and 50 kg. All of the experiments were
performed under general anesthesia and all of the animals
were killed after the experiments. The operations were
performed by the same team of surgeons (the first five
authors).
Eighteen large, white Landrace pigs (weighing 17 to
20 kg) underwent OLT with whole liver grafts and were
divided randomly into three experimental groups, as
follows:
1- Control group (n = 6): the weights of the donors were
similar to the recipients (17-20 kg);
2- Large-for-size group (LFS, n = 6): the weights of the
donors were nearly 2 times the weights of the recipients
(40-50 kg);
3- Large-for-size + ischemic preconditioning (LFS + IPC,
n = 6): the weight distributions were similar to the LFS
group and IPC was performed in the donors.
Anesthetic procedures and intraoperative
monitoring
After fasting for a period of 12 hours, the donors were
anesthetized and maintained with a continuous intravenous
infusion of 0.005 mg/kg/h fentanyl and 3.5 mg/kg/h
propofol.
After an open cut was made down the right carotid sheath, a
double lumen catheter was placed into the internal jugular
vein for invasive venous pressure monitoring and fluid
administration. In addition, a single lumen catheter was
inserted into the carotid artery for arterial pressure monitoring.
A total volume of approximately 300 ml of blood was
collected from the donors before liver perfusion for infusion
into the recipient pigs if necessary.
Donor procedure
In the donor operation, a long, longitudinal, midline
thoracic and abdominal incision was performed to widely
expose all organs. The portal vein, infrahepatic inferior vena
cava and suprahepatic inferior vena cava were dissected.
The hepatic artery was maintained in continuity with the
celiac trunk and abdominal aorta up to the iliac bifurcation.
In situ cold liver perfusion (with Euro CollinsH and Ringer’s
lactate solutions) was then performed through both the
portal vein and the aorta. The harvested graft was weighed,
immersed in a plastic bag filled with Euro CollinsH
perfusion solution at 4 C˚ and placed in a basin for the
subsequent back-table procedure.
In the donors of the LFS + IPC group, after opening the
abdominal cavity, the hepatic hilum was clamped with a
vascular clamp. Blood flow was stopped for 15 minutes,
followed by reperfusion for 15 minutes.
Recipient procedure
A total hepatectomy was performed via a longitudinal
incision and the supraceliac aorta was dissected close to the
diaphragmatic crura and clamped during the anhepatic
phase. The graft was put in place and the suprahepatic
inferior vena cava, infrahepatic inferior vena cava and portal
vein were anastomosed. Before the completion of infrahepa-
tic inferior vena cava anastomosis, the graft was flushed with
1 L of saline solution at 4 C˚ though the portal vein.
All anastomoses were performed using continuous
Prolene 5-0 or 6-0 sutures. After completion of the venous
anastomoses, the liver graft was reperfused. The recipient
hepatic artery was anastomosed to the donor celiac trunk
patch. The biliary reconstruction consisted of a choledo-
chus-choledochus stented anastomosis.
The abdominal wall was kept open and only a few stitches
were placed in the skin to retain the bowels and to avoid
hypothermia. After 3 hours, the animal was euthanized.
Blood and serum analyses
Blood from the recipient was sampled at baseline and at 1
and 3 hours after portal reperfusion for the evaluation of the
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pH and the sodium and potassium levels. Aspartate
aminotransferase (AST) and alanine aminotransferase
(ALT) levels were measured in the blood samples collected
1 and 3 hours after reperfusion.
Tissue analyses
Hepatic tissue was sampled from the recipient at 1 and
3 hours after portal reperfusion. Each biopsy sample was
divided into two sections. One was preserved in 10%
formaldehyde for subsequent embedding in paraffin and
the other was snap-frozen in liquid nitrogen at 2170 C˚ for
molecular analyses.
Histological examination was performed via hematox-
ylin-eosin staining and light microscopy for the presence of
centrilobular necrosis, sinusoidal neutrophils, steatosis,
apoptotic bodies and sinusoidal dilatation. For each of these
parameters, the following scoring system was used:
0 - absent; 1 - mild; 2 - moderate, 3 - intense; 4 - very intense.
& IMMUNOHISTOCHEMICAL METHODS
Detection of hepatocyte apoptosis
For the detection of early apoptosis, M30 CytoDEATH, a
mouse monoclonal antibody (Clone M30, Roche,
Mannheim, Germany), was used to detect a specific epitope
of cytokeratin 18 (cleaved cytokeratin 18), which is
produced after cleavage by caspase.
The paraffin-embedded liver tissue specimens were
sectioned into 5-mm-thick sections. These sections were
dewaxed in xylene and hydrated in graded concentrations
of alcohol. Endogenous peroxidase activity was blocked
with 3% H2O2 in methanol for 15 minutes.
The M30 CytoDEATH (Roche) antibody was used at a
dilution of 15100 for 1 hour at room temperature. The
sections were then incubated with anti-mouse-Ig Biotin
(Chemicon AP302B) at 37 C˚ for 30 minutes, followed by
Streptavidin-POD (Roche) for 30 minutes. The location of
the antibody was detected using diaminobenzidine, (DAB,
SigmaH) before the sections were counterstained with
hematoxylin, dehydrated with graded alcohol concentra-
tions (70%, 90%, 100%) and Histoclear, and mounted with
Entellan (Merck).
Detection of hepatocyte proliferation
To quantify cellular proliferation, immunohistochemical
staining for Ki-67 was performed on the liver tissue samples
using a rabbit anti-human Ki-67 monoclonal antibody
(Clone SP6, Spring Bioscience, Pleasanton, California, USA).
Ki-67 is a nuclear protein that is detected in all active
stages of the cell cycle except for G0 (quiescent) and is
therefore a marker of cellular proliferation.
After fixation with 10% formaldehyde, the liver tissues were
embedded in paraffin, cut into 5-mm-thick sections, depar-
affinized and hydrated. The sections were then processed for
antigen recovery, endogenous peroxidase blocking and
immunohistochemical detection of Ki-67. For that purpose,
the sections were incubated with the rabbit anti-human Ki-67
monoclonal antibody (Clone SP6, Spring Bioscience,
Pleasanton, California, USA) at a 15100 dilution. Staining
was performed using DAB, followed by counterstaining with
Harris hematoxylin, dehydration, and mounting with
Entellan (Merck).
The stained tissue sections were examined at magnifica-
tions of 1506, 6006 and 15006 (under oil immersion) by a
researcher who was blinded to the experimental groups.
The stained hepatocyte nuclei were counted at a magnifica-
tion of 6006 using an ocular lens containing a 1-cm2 grid
(Nikon). Among all of the nuclei included in the grid area
(500 – 800 nuclei), all nuclei stained for Ki-67 and cleaved
cytokeratin 18 were counted and expressed as percentages
of the total number of nuclei.
Molecular analysis
The expression of the pro-apoptotic Bax, anti-apoptotic
Bcl-XL, IEGs c-Fos and c-Jun, IL-1, IL-6, TNF-alpha, TGF-beta,
ICAM and eNOS genes were evaluated using quantitative
reverse-transcriptase polymerase chain reaction (qRT-PCR).
In all experiments, the b-actin gene was used as a house-
keeping control gene.
Total RNA was isolated from all liver samples using
the TRIzol reagent (Invitrogen, Carlsbad, CA, USA).
Approximately 100.0 mg of tissue was fragmented (Mikro-
Dismembrator U; Sartorius AG, Goettingen, Germany) after
the addition of liquid nitrogen and homogenization in 1 mL
of TRIzol reagent. The RNA was then isolated following
standard procedures. Total RNA was quantified by spectro-
photometry via a Biophotometer (Eppendorf AG, Hamburg,
Germany) at an absorbance of 260 nm and the purity was
assessed by measuring the 260/280 nm ratio. This ratio
ranged from 1.8 to 2.0 for all samples.
The integrity of the isolated RNA sample was assessed by
denaturing agarose gel electrophoresis through the visuali-
zation of the 18S and 28S ribosomal RNA bands after
ethidium bromide staining. Complementary DNA (cDNA)
was prepared from 2.0 mg of total RNA by reverse
transcription using 200.0 U of SuperScript III RNase H-RT
(Invitrogen) and oligo (dT)s as primers. The resulting cDNA
solution was stored at 220 C˚.
Quantitative real-time PCR was performed in a 15.0-mL
reaction mix using 7.5 mL of Platinum SYBER Green qPCR
SuperMix-UDG (Invitrogen Carlsbad, CA-USA), 0.3 mL of
gene-specific forward and reverse primers (10 mM), 1.0 mL
of cDNA, and 5.9 mL of nuclease-free water. The primers
used are shown in Table 1.
The cycling conditions were as follows: initial template
denaturation at 95 C˚ for 1 minute, followed by 40 cycles of
denaturation at 95 C˚ for 20 seconds, annealing at 60 C˚ for 30
seconds, and extension at 72 C˚ for 30 seconds. The reactions
were prepared separately for each of the genes and were
amplified in a Rotor-Gene RG-3000 (Corbett Research,
Australia). The reactions were run in triplicate. Blank
controls were included in parallel for each master mix.
Amplification was followed by a melting curve analysis to
check the PCR product specificity. The data were analyzed
by relative quantification and the 22DDCt value was
calculated (23).
Statistical analysis
Data were stored in Microsoft Excel and transferred to R
(www.r-project.org) for statistical analysis and figure crea-
tion. The anthropometric and blood analysis data were
compared using analysis of variance with a post-hoc Tukey
test because the data followed a parametric distribution. The
results of the immunohistochemical analyses are shown as
the median (minimum and maximum values). The results of
the molecular analyses are presented as the 25th and 75th
percentiles, the median and the minimum and maximum
values in box-plot graphics. The differences between the
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groups were compared using a nonparametric Kruskal-
Wallis test followed by Dunn’s multiple comparisons test.
Differences with a p value less than 0.05 were considered
significant.
& RESULTS
The mortality rate was 16.5% (1/6) in all groups. The
death in the control group was related to bleeding from a
laceration on the graft surface. In the LFS and LFS + IPC
groups, the deaths were associated with hemodynamic
instability immediately after aortic unclamping.
The anthropometric data and transplant characteristics of
the groups are shown in Table 2. The recipient weights, total
ischemia times and warm ischemia times were similar
between the groups. The donor weights and GBWRs were
significantly higher in the LFS and LFS + PCI groups
(p= 0.005).
Blood analysis: All animals developed acidosis, but there
was no difference in the pH values among the groups
during the procedure. At 1 hour and 3 hours after reperfu-
sion, the animals in the LFS and LFS + IPC groups had
decreased serum levels of Na and increased serum levels of
K compared with the control group (Figure 1). The AST
levels were markedly higher in the LFS and LFS + IPC
groups at both 1 and 3 hours after portal reperfusion
compared with the control group. No alterations were
observed in the levels of ALT (Figure 2).
Tissue analysis: Histological alterations were observed in
all groups, including marked sinusoidal dilatation and the
presence of sinusoidal neutrophils and steatosis (Figure 3).
However, there was no difference between the experimental
groups regarding these findings.
Immunohistochemical analysis: The numbers of hepato-
cytes that stained positive for Ki-67, expressed as the
percentage of the total number of counted cells, are shown
in Table 3. The comparisons between the groups demon-
strated that there were no significant differences. Regarding
the apoptotic index represented by cleaved cytokeratin-18-
positive cells, the statistical analysis showed that there were
no differences between the groups.
Molecular analysis: The results of the molecular analyses
are shown in Figure 4. Higher Bax gene expression was
observed at 3 hours after reperfusion in the LFS group
compared with the control and LFS + IPC groups (p= 0.004
and p= 0.002, respectively). Bcl-XL gene expression did not
differ among the groups. c-Fos gene expression was higher
in the LFS + IPC group compared with the control and LFS
groups (p= 0.02 and p= 0.004, respectively). This elevated
gene expression persisted after 3 hours of reperfusion
(p= 0.02 compared with the control group). c-Jun gene
expression did not differ among the groups and the times
after reperfusion.
Regarding cytokines, adhesion molecules and e-NOS,
elevated TNF-alpha gene expression was observed in the
LFS group compared with the LFS + IPC group (p= 0.015
and p= 0.043 1 hour and 3 hours after reperfusion, respec-
tively). I-CAM expression was elevated at 3 hours after
reperfusion in the LFS group compared with the control and
LFS + IPC groups (p= 0.026 and p= 0.009, respectively).
After 1 hour, no differences were observed. IL-1 and e-NOS
gene expression was significantly elevated in the LFS + IPC
group compared with the control, at both time points after
reperfusion (p= 0.004 and p= 0.002; p= 0.003 and p= 0.028,
respectively). Additionally, e-NOS gene expression was
elevated in the LFS + IPC group compared with the
LFS group, 3 hours after reperfusion (p= 0.017). IL-6 gene
expression in the LFS+IPC group was increased 3 hours
after reperfusion compared to the control group (p= 0.03).
Finally, TGF-beta gene expression was elevated in the
LFS group compared with the control and LFS + IPC
groups at both time points after reperfusion (p= 0.009 and
p= 0.012 after 1 hour; p= 0.026 and p= 0.021 after 3 hours,
respectively).
& DISCUSSION
Given the complexity of liver transplantation in children,
the difference between the recipient weight and the size of
liver grafts that are most commonly harvested from adults
may lead to an LFS clinical scenario, which can involve
multiple complications.
We previously reported an original LFS experimental
model of liver transplantation in large animals with aortic
clamping (23). One technical difficulty in porcine liver
transplantation is the occasional lethal hemodynamic
instability caused by simultaneous portal and caval clamp-
ing; to compensate for this, venovenous bypass (VVB) is
often used during the anhepatic phase (24). However, VVB
substantially increases the morbidity and complexity of the
Table 1 - Primer sequences.
Gene Primers
b actin Sense: 59-tcc aga ggc gct ctt cca-39
Antisense: 59-cgc act tca tga tcg agt tga-39
Bax Sense: 59-ctg gga ctt ctt gct gga ttt gc-39
Antisense: 59-cag ggt gaa gca ggt gaa gat c-39
Bcl-XL Sense: 59-gga gct ggt ggt tga ctt tc-39
Antisense: 59-gtt tcc tct tct gat tca gtc-39
eNOS Sense: 59-aca tct gca acc aca tca agt acg-39
Antisense: 59-cac cag ttg gct gtt cca gat c-39
IL-6 Sense: 59-cga gcc cac cag gaa cga aag-39
Antisense: 59-aag cag ccc cag gga gaa ggc-39
IL-1 Sense: 59-caa gga cag tgt ggt gat gg-39
Antisense: 59-cat cat tca gga tgc act gg-39
TGF-beta Sense: 59-cct gga tac caa cta ctg ctt c-39
Antisense: 59-gtg tct agg ctc cag atg tag g-39
TNF-alpha Sense: 59-cca cca acg ttt tcc tca ct-39
Antisense: 59-ggc act gag tcg atc atc ct-39
c-Fos Sense: 59-acg gtg act gct atc tcg ac-39
Antisense: 59-tct tct tct ggg gac aac tg-39
c-Jun Sense: 59-acc ttg aaa gcg cag aac tc-39
Antisense: 59-aac agt ctc gcc tca aaa cg-39
ICAM Sense: 59-ttc ctt gga tgg act gtt cc-39
Antisense: 59-cgt ctg cca gca tta tct ca-39
Table 2 - Anthropometric data and transplant
characteristics of the groups (mean ¡ sd).
Control LFS LFS + IPC
Donor weight (kg) 20.3¡0.58 44.8¡6.21* 48.24¡2.89**
Recipient weight (kg) 20.86¡1.08 22.2¡4.76 20.6¡2.79
GBWR 2.9¡0.22 6.3¡0.73* 6.4¡0.98***
Total ischemia time (min.) 138.8¡17.8 147.6¡8.3 152.0¡14.5
Warm ischemia time (min.) 44.8¡3.7 46.8¡2.7 47.0¡3.4
*p=0.005 relative to control.
**p=0.001 relative to control.
***p=0.004 relative to control.
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procedure (25,26). Aortic clamping during the anhepatic
phase is well tolerated, results in excellent hemodynamic
stability and considerably reduces the operative time
because VVB and mesocaval anastomosis construction
become unnecessary (27). Although there are potential
harmful consequences of aortic clamping, these complica-
tions are dependent on the level of aortic cross clamping
(clamping of the thoracic aorta produces more complica-
tions than clamping of the infrarenal aorta), the duration
and patient comorbidities (28). In our experiments using
young, healthy pigs and an anhepatic phase lasting no more
than 45 minutes, we believe that the complication rate
should be low.
Up to 60% of the indications for liver transplantation in
children are due to biliary atresia (1), a condition that
progresses with hypoplasia or even thrombosis of the portal
vein (29) and these complications lead to an early indication
for liver transplantation. The low flow in the portal vein
results in difficulty with graft perfusion and this difficulty
can be even more pronounced when the graft is relatively
large. Using a flowmetry study, we compared portal flow in
control and LFS pig liver transplantations. We observed a
significant decrease in portal flow from the donor to the
recipient in the LFS group, and this decrease was correlated
with the higher expression of inflammatory genes related to
IRI and progressive elevation of AST levels (30). To simulate
the clinical situation in humans, we initially attempted to
use pigs weighing approximately 10 kg, but they were still
suckling and did not tolerate the procedure; deaths occurred
during the anhepatic phase. Therefore, we began to use
weaning pigs (weighing approximately 20 kg), which
produced better survival indices.
Figure 1 - The results of serum analyses. There were no differences in the pH values among the groups. Decreased serum levels of Na
and increased serum levels of K were observed at 1 hour and 3 hours after reperfusion in the LFS and LFS + IPC groups compared with
the control group (p=0.021 and p=0.047 for Na values and p=0.028 and p=0.004 for K values, respectively).
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In the present study, we aimed to assess the early phase of
IRI in LFS transplantation cases. The abdominal cavity was
kept open after the experiment in an attempt to avoid the
deleterious effects of increased abdominal pressure and
inferior vena cava obstruction.
The GBWR was significantly higher in the LFS and LFS +
IPC groups (mean 6.3% and 6.4%, respectively). This ratio is
consistent with liver transplantation in children. Although
the numbers of transplantations and recipients per group
were not high, they were similar to many pig experimental
studies in the literature. The complexity of the procedure
and the difficulties associated with the maintenance of large
animals in urban laboratories justify the low number of
animals per group in the current study. However, this
number was sufficient to detect many significant differences
among the groups. Another point of discussion is the cold
ischemia time, which was relatively short compared with
liver transplantations with cadaveric donors but prolonged
compared with liver transplantations with living donors,
which represent the majority of pediatric transplantations in
many centers. Although the period of three hours after
reperfusion is a relatively short follow-up, we focused our
study on the early repercussions of IRI and the expression of
genes that are triggered immediately in this process. Thus,
the present model is suitable for assessing injury in the LFS
Figure 2 - The AST levels were markedly higher in the LFS and LFS + IPC groups at 1 and 3 hours after portal reperfusion compared with
the control group (p=0.013 and p=0.002, respectively). No alterations were observed in the ALT levels.
Figure 3 - The histological aspects of a transplanted liver at
3 hours after reperfusion. Note the presence of sinusoidal
dilatation, steatosis and sinusoidal neutrophils.
Table 3 - Results of immunohistochemical analyses
(median, minimum and maximum values). No differences
were observed among the groups.
Control LFS* LFS + IPC*
1 h 3 h 1 h 3 h 1 h 3 h
Ki-67 10 (5-10) 15 (8-25) 7.5 (3-15) 20 (6-25) 15 (6-25) 10 (3-15)
Cytokeratin 1 (0-3) 2 (0-4) 2 (1-5) 1 (0-3) 1 (0-4) 2 (0-4)
*p=0.7 and p=0.8 relative to the control group at 1 h and 3 h,
respectively, for Ki-67.
*p=0.6 and p=0.8 relative to the control group at 1 h and 3 h,
respectively, for cytokeratin.
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Figure 4 - The results of molecular analyses. Note the positive effects of IPC on gene expression.
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scenario and we aimed to evaluate acute graft lesions in this
context.
The standardization of the IPC interval (15 minutes of
portal clamping followed by 15 minutes of reperfusion) was
based on a literature review. Schulz et al. demonstrated in a
study conducted in pigs that IPC with 10-minute intervals
had no protective effect on IRI (31), whereas the utilization
of longer IPC times (15 minutes) produced significant effects
(32). Similar to the clinical scenario, all animals developed
acidosis that was not related to the size of the graft because
there were no differences in the pH values between the
groups. The acidosis was likely related to conditions of
hypoperfusion caused by the clamping of the inferior vena
cava and the portal vein during the anhepatic phase in
addition to the clamping of the aorta.
Hyperkalemia was observed in all groups, especially in
the first hour after reperfusion. This condition is also similar
to that observed in clinical transplantation. The liver graft,
which is stored in a cold preservation solution, is the main
source of potassium in this situation. During reperfusion, a
large quantity of potassium is released from the graft into
the bloodstream (33,34). Higher values were observed in the
LFS and LFS + IPC groups and as described above, this can
be attributed to the higher mass of the transplanted liver
graft. After 3 hours, the serum potassium values in the LFS
and LFS + IPC groups decreased and were comparable to
the control group values.
Intraoperative natremia disturbances are less often
discussed in the literature. The sodium values were lower
in the LFS and LFS + IPS groups one hour after reperfusion.
During the period of ischemia, cellular swelling occurs
because of the influx of sodium and water into the
intracellular space (35). As the liver mass was higher in
the LFS and LFS + IPC groups, this result may have been
caused by a greater accumulation of intracellular sodium in
these groups.
The pathophysiology of hepatic ischemia/reperfusion
injury (IRI) includes a number of complex and diverse
mechanisms involving the interactions between hepato-
cytes, Kupffer cells, neutrophils, macrophages, sinusoidal
endothelial cells and platelets. IRI is one of the main causes
of graft dysfunction after transplantation and contributes to
decreased graft and patient survival (14-16). Therefore, the
identification of the factors that contribute to increased
tissue damage, as well as measures to attenuate this
damage, is critical to improving survival. In the current
investigation, we aimed to study whether IPC has positive
effects on the graft in the experimental LFS liver transplan-
tation model. IPC consists of an adaptive mechanism in
which brief episodes of ischemia protect an organ from
injury caused by prolonged ischemia. IPC contributes to
improving hepatic microcirculation and regeneration,
thereby attenuating IRI. Biochemical, histological and
molecular biology analyses were used in this study to
evaluate the effects of IRI and IPC in the LFS liver
transplantation model.
The serum AST levels were higher in the LFS and LFS +
IPC groups during both time periods studied. This change
highlights the potential deleterious effect of implanting a
disproportionately large graft into a recipient. The AST
levels in the LFS group increased from the first to the third
hour after reperfusion; however, in the LFS + IPC group, the
AST levels tended to decrease from the first to the third
hour. Similarly, immunohistochemical analyses of cellular
proliferation revealed that IPC was responsible for a
tendency towards an increased peak in Ki-67 expression.
These facts may suggest that IPC provokes an earlier but
less harmful response to IRI.
The histological analysis revealed no differences between
the groups. This result is most likely explained by the fact
that the study only analyzed the acute phase of the
experiment. Nevertheless, it is important to note that some
typical IRI-related changes, such as the presence of
sinusoidal dilatation, sinusoidal neutrophils and hepatic
steatosis, were observed.
Apoptosis was evaluated based on Bax (pro-apoptotic)
and Bcl-XL (anti-apoptotic) gene expression. Bax gene
expression was significantly higher in the LFS group
compared with the control and LFS + IPC groups at 3 hours
after reperfusion. This finding supports the hypothesis that
apoptosis due to IRI is exacerbated in LFS scenarios. In
addition, IPC plays a protective role by decreasing Bax gene
expression.
Regarding the anti-apoptotic effects of IPC, Bcl-XL gene
expression did not differ between the studied groups, but
there was a tendency for higher Bcl-XL expression in the
LFS + IPC group at 3 hours after reperfusion. The difference
between the LFS and LFS + IPC groups almost reached
statistical significance (p= 0.05), demonstrating that IPC
likely plays an anti-apoptotic role in IRI.
The co-existence of apoptosis and hepatocyte regenera-
tion in IRI shows that liver tissue remodeling is regulated by
both processes. IEGs are important factors in the cellular
proliferation induced by IRI as a part of tissue repair (9,10).
Cells lose the ability to respond to proliferation signals by
the blockade of Fos protein; thus, c-Fos is considered an
important factor in the cell regeneration signal transduction
pathway (36). Some studies suggest that the apoptosis/
proliferation processes are doubly regulated by different c-
Fos and c-Jun mRNA expression levels. c-Fos/c-Jun hetero-
dimers are thought to promote cell regeneration and c-Jun
homodimers may lead to cell apoptosis (10,11). In fact, we
observed that c-Jun levels were similar in all groups;
however, IPC was responsible for increasing c-Fos levels.
This result may be one explanation for the protective effect
of IPC against hepatocyte apoptosis.
Tumor necrosis factor-a (TNF-a), a cytokine produced by
numerous cell types in response to inflammatory stimuli, is
a well-known mediator during ischemia/reperfusion (IR)
that plays a central role in hepatocyte injury. TNF-a has a
multifactorial effect in hepatic IRI because of the many
interactions between TNF-a and reactive oxygen species,
nitric oxide, adhesion molecules, and various cytokines and
chemokines (37). Zhang et al., studying the action of mast
cell stabilization in acute lung injury after autologous
orthotopic liver transplantation in rats, observed an upre-
gulation of the serial pro-inflammatory cytokines TNF-a, IL-
1-beta and IL-6, peaking at 4 hour after reperfusion (38). In
our study, transplantation of a disproportionally large graft
was responsible for increased TNF-a expression compared
with the control group; this may be related to increased
ICAM expression, suggesting more intense IRI in the LFS
situation. Cziga´ny et al., studying the effects of remote
ischemic preconditioning in liver IRI in rats, observed that
preconditioning was responsible for a protective effect on
liver morphology and was associated with a decrease in
TNF-a serum levels (39). Analogously, ischemic precondi-
tioning was responsible for decreased TNF-a levels as well
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as decreased ICAM expression in the LFS situation, thereby
attenuating IRI.
Interestingly, in our study, IPC led to an increase in IL-1
expression. Shin et al., analyzing IPC-induced neuroprotec-
tion, observed that IPC was responsible for a parallel
increase in IL-1b and IL-1 receptor antagonist expression in
the ischemic cortex, resulting in a significant reduction in
the brain cortex infarct area (40). Unfortunately, we did not
measure IL-1 receptor antagonist expression, but it is
reasonable to assume that in the LFS+IPC group, higher
IL-1 receptor antagonist expression would also be observed.
Along these lines, eNOS gene expression was significantly
higher in the LFS + IPC group than in the other groups at
3 hours after reperfusion. IPC resulted in increased eNOS
expression. This enzyme is responsible for NO production,
which in turn contributes to improving microcirculation,
thereby reducing tissue injury (41). Liver regeneration is
closely related to the expression of IL-6, which is released in
IRI by Kupffer cells. Previous studies have demonstrated
the role of IL-6 in liver regeneration and the increased
release of IL-6 promoted by IPC (20,42). At 1 hour after
reperfusion, there was no difference between the groups.
However, after 3 hours, IL-6 gene expression was higher in
the LFS + IPC group. This finding suggests that IL-6, along
with other factors, may play an important role in the
protective mechanisms of IPC in attenuating IRI.
A relationship between IRI and the stimulation of
fibrogenesis has been suggested and studied in the
literature. TGF-beta is one of the main cytokines related to
liver fibrogenesis and has been related to the transdiffer-
entiation of stellate cells into myofibroblasts and to the
deposition of portal collagen. Yu et al., using a model of
selective portal vein ligation, aimed to determine whether
IR in clamped lobes facilitated liver regeneration of non-
clamped lobes (43). In fact, the authors observed that IR
pretreatment of the clamped lobes facilitated the liver
regeneration of non-clamped lobes after selective portal
vein ligation, which may have resulted from down-
regulated TGF-beta 1 expression in the non-clamped lobes.
Our results suggest that the more intense IRI in the large
graft stimulated TGF-beta production and that IPC is
responsible for the attenuation of these liver fibrogenesis
stimuli.
In summary, IRI is more pronounced in this model of LFS
liver transplantation and is partially attenuated by IPC,
mainly through the improvement of the gene expression of
early molecular markers. The long-term implications and
the graft and animal survival were not examined in this
study because this research was conducted to assess the
acute phase of IRI. Future studies to evaluate the long-term
outcomes, liver perfusion and techniques to modify liver
perfusion are important to establish a better understanding
of the biological processes involved in this scenario.
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